Nefense, a company specializing in advanced clinical hygiene and airway health solutions, has announced the launch of its Hypochlorous Acid (HOCl) nasal spray line. The product family includes Hyponasal for adults, Hyponasal Junior for children, and Hypobaby for infants, providing age-specific, drug-free nasal care options. These sprays are designed to support airway health, nasal hygiene, and respiratory wellness by leveraging the natural antimicrobial and anti-inflammatory properties of HOCl, a molecule produced by the human immune system.
According to Dr. Richard D. Downs, D.D.S., "Proper airway management begins with maintaining a clean and healthy nasal cavity. With Hyponasal, we are providing a superior biocleanse solution that addresses daily irritation at its source." The flagship product, Hyponasal HOCl Nose Spray, aims to flush away environmental irritants without harsh chemicals, medications, or steroids, offering a soothing alternative for daily nasal hygiene.
The science behind HOCl has gained attention in healthcare settings for its ability to support a cleaner nasal environment while promoting healthy respiratory function. Dr. Joseph Zelk, a sleep specialist collaborating with Nefense on airway optimization, noted, "The anti-inflammatory and antimicrobial properties of HOCl make it a remarkable tool for naturally clearing the airway, mitigating allergies, and supporting healthier breathing." The pediatric formulations, Hyponasal Jr. and Hypobaby, are tailored for sensitive nasal passages, providing a non-stinging option for managing congestion associated with environmental and seasonal challenges.
Dr. Shane Smith emphasized the importance of safe solutions for children, stating, "Parents constantly struggle to find safe, drug-free solutions for their children’s congestion. Hypobaby and Hyponasal Jr. offer unparalleled peace of mind." The launch addresses growing consumer interest in respiratory wellness, including airway hygiene, healthy breathing habits, and drug-free allergy management. For more information, visit Nefense.com.
